Ras proto-oncogene GTPase (specifically, for most references: HRas, KRas, or NRas GTPase depending on context; often just "Ras protein" or "Ras GTPase") (Ras (for the protein family); HRas, KRas, NRas (for isoforms))

Ras proto-oncogene GTPases are small, single-subunit GTPase enzymes that act as molecular switches in cell signaling. They cycle between an active (GTP-bound) and inactive (GDP-bound) state, controlling downstream signal transduction pathways crucial for cell growth, differentiation, survival, and metabolism. When mutated (especially at residues G12, G13, or Q61), Ras proteins become constitutively active, driving uncontrolled cell proliferation and cancer. Ras proteins mediate transduction of signals from cell surface receptors to the nucleus via the MAPK and PI3K pathways and are central to oncogenic processes in diverse malignancies[1][2][5][6][3]. Targeting mutated Ras and its downstream effectors is a key focus in cancer therapeutics, though direct inhibition remains challenging due to structural constraints. Ras function is regulated by guanine nucleotide exchange factors (GEFs), GTPase activating proteins (GAPs), and post-translational lipid modifications for membrane localization[1][2][4].

Other names

Ras proteinRas GTPaseHRasKRasNRasRASras oncogeneproto-oncogene Ras

Inhibit Ras nucleotide exchange (prevent activation from GDP-bound to GTP-bound). Block Ras-effector interaction (disrupt signaling with RAF, PI3K, etc.). Inhibit post-translational modifications essential for membrane localization. Downregulate downstream MAPK or PI3K/AKT pathway activity.